|
|
||||||||
Eur J Cardiothorac Surg 2005;28:754-758
© 2005 Elsevier Science NL
a Division of Thoracic Surgery, Department of Surgical Science, University of Parma, U.O. Chirurgia Toracica, Azienda Ospedaliera di Parma, Viale Gramsci 14, 43100 Parma, Italy
b Division of Respiratory Diseases, Department of Clinical Science, University of Parma, Italy
c Department of Public Health, University of Parma, Parma, Italy
Received 25 May 2005; received in revised form 26 July 2005; accepted 2 August 2005.
* Corresponding author. Tel.: +39 3406874733; fax: +39 0521992019. (Email: antonio.bobbio{at}unipr.it; antonboa{at}hotmail.com).
| Abstract |
|---|
|
|
|---|
Key Words: Exercise capacity Pulmonary function Lobectomy COPD
| 1. Introduction |
|---|
|
|
|---|
For this purpose, the preoperative measurement of exercise capacity (EC), defined as maximal oxygen uptake at peak of exercise (VO2max), has been reported as being a better predictor of postoperative complication and mortality than resting pulmonary and cardiac function testing [13]. With the aim of evaluating the residual EC after pulmonary resection, several authors have studied the modifications of VO2max after lung surgery, and have attempted to correlate the amount of lung tissue loss with the postoperative modifications of EC [49]. However, scant information exists as to the modification of EC in patients with COPD undergoing lung resection, and since even a mild form of COPD can be responsible for exercise intolerance with symptom limitation [1012], it seems crucial to understand the changes in cardio-pulmonary function in COPD patients undergoing lung surgery.
The primary objective of the study was to quantify EC loss after a lobar pulmonary resection in patients with a preoperative diagnosis of COPD. For this purpose, the preoperative data of resting Pulmonary Function Test (PFT) and cycle-ergometric Cardio-Pulmonary Exercise Test (C-PET) were collected and compared to those measured 3 months after a lobar pulmonary resection. Duration of hospital stay and outcome of surgery including complications and mortality were also documented.
| 2. Materials and methods |
|---|
|
|
|---|
2.1 Spirometry and C-PET measurement
All lung function parameters were measured at the Division of Respiratory Diseases of the Department of Clinical Sciences at the University of Parma. PFTs were done with a flow-sensing spirometer and a body plethysmograph connected to a computer for data analysis (Vmax 22 and 6200, Sensor Medics, Yorba Linda, US); Forced Expiratory Ventilation in 1 second (FEV1), Total Lung Capacity (TLC) and Carbon Monoxide Transfer Capacity (DLCO) as absolute value and as percentage of predicted value were noted.
The C-PET evaluation consisted of exercise capacity assessment by an incremental exercise test using an electronically braked cycle ergometer (Corival PB, Lode BV, Groninger, The Netherlands). After a 3-min period of rest and a 3-min period of unloaded pedaling, patients cycled at 60 rpm with an incremental load of 515/W up to exhaustion (i.e. inability to maintain a constant speed of at least of 50 rpm and/or intolerable dyspnea). Oxygen uptake (VO2, ml/min), CO2 production (VCO2, ml/min) and minute ventilation (VE, L/min) were computed according to breath-by-breath analysis; data were displayed using an on-line computer (Vmax 229, Sensor Medics, Yorba Linda, US). If detectable, the Ventilatory Anaerobic Threshold (AT) was determined, according to the V-slope method and/or ventilatory equivalent method. The heart rate was monitored continuously by electrocardiography (Corina, GE Medical Systems IT inc., Milwaukee, USA) and oxygen saturation (SpO2, %) by pulse oxymetry (Nonin, Medical Inc, MPLS, MN, US). When patients had completed the exercise capacity test, they were asked to record on a visual analogue scale (0100 mm) the reason for stopping, both as leg discomfort (VAS leg) and as dyspnea (VAS dys).
2.2 Statistical analysis
Computations were performed using the SPSS for Windows statistical software package (SPSS° Inc., version 12.0, Chicago, IL). Data are expressed as mean ± standard deviation (SD) with range in brackets. Comparison of mean values was done with the Wilcoxon range test for non-parametric variance analysis.
| 3. Results |
|---|
|
|
|---|
3.1 Surgical results
Ten patients underwent surgery for NSCLC and one for pulmonary aspergilloma. Nine patients underwent a lobectomy: three upper right, 5 upper left and 1 right inferior. Two had an inferior right bilobectomy. All patients were admitted postoperatively to the intensive care unit (IUC) and discharged after 24 h. No readmission to the IUC was noted. No postoperative deaths occurred, and mean recovery time was 12 days (range 814 days). Postoperative complications were noted in 6 patients (55%). In 4 patients, a diagnosis of clinical sputum retention necessitating a suction fiber-optic bronchoscopy was made; because of persistent sputum retention 24-h after bronchoscopy, three of these patients underwent a 4 mm diameter percutaneous cricothyroid mini-tracheostomy (Mini-Trach II, Portex°). All patients recovered. There were two cases of postoperative prolonged pulmonary air leak. These patients were both discharged from hospital with the pleural drain connected to a Heimlich valve. The drain was removed with no late complications at outpatient visit. Two patients had a postoperative supraventricular arrhythmia, successfully treated during the recovery period with amiodarone.
3.2 Data of preoperative and postoperative functional evaluation
Preoperative PFT and C-PET data are shown in Tables 1 and 2
, respectively. Postoperative PFT data are shown in Table 3
and postoperative C-PET data in Table 4
. The postoperative C-PET was done after a mean interval of 109 days (±19 days). Changes between pre- and postoperative mean values of PFT are shown in Fig. 1
. No significant changes resulted in FEV1 (P
= 0.959) and DLCO values (P
= 0.139); in contrast, TLC significantly decreased from a mean of 120% to a mean of 99% of the predicted value. Preoperative C-PET evaluation revealed a mean VO2max at 1.326 Lt./min (17.8 ml/Kg/min referenced to body weight in kilograms), which decreased to a mean value of 1.048 Lt./min (14.1 ml/Kg/min) on postoperative evaluation (P
= 0.003), corresponding to a postoperative loss of 21% in VO2max. Preoperatively mean value of VO2max measured at the anaerobic threshold (VO2max at AT) resulted as being 1.010 Lt./min, which represented 60% of the VO2max peak. Postoperatively only 6 patients reached the anaerobic threshold during exercise, and among these patients the mean value of VO2max at AT resulted as being 0.932 Lt./min, which represented 50% of the VO2 max peak. The slope between minute ventilation and CO2 production (VE/VCO2), corresponding to the liters of air needed to eliminate one liter of CO2 and which normally ranges between 25 and 30, [14] was found, preoperatively, to have increased to a mean value of 35 (SD ± 4). Postoperatively the relationship increased significantly, to a mean value of 42 (SD ± 12) (P
= 0.018). The mean preoperative peak heart rate was 141/bpm, which decreased postoperatively to 123/bpm. The ratio of VO2max to heart rate, conventionally termed Oxygen Pulse (O2 pulse), slightly decreased from a mean preoperative value of 8.8 ml/bpm (SD ± 1.2) to a postoperative mean value of 8.6 ml/bmp (SD ± 3.1). The mean workload decreased from a preoperative mean value of 89 W (SD ± 36) to a postoperative mean value of 66 W (SD ± 26). Evaluation of limiting factor to exercise by VAS found a stable predominant sensation of dyspnea versus leg fatigue.
|
|
|
|
|
| 4. Discussion |
|---|
|
|
|---|
Various authors have studied the changes in EC after pulmonary resection. Pelletier et al. [4] found, 3 months after surgery, a loss of 20% in EC after lobectomy and of 28% after pneumonectomy. Larsen et al. [5] reported, 6 months after surgery, a non-significant loss of 12.9% after lobectomy and a significant loss of 16% after pneumonectomy; at the same point in time of postoperative functional evaluation, Bollinger et al. [6] reported no residual functional loss after lobectomy and a permanent loss of 20% after pneumonectomy. The latter author, evaluating separately the subgroup of patients with an impaired preoperative pulmonary function, reported that the EC modifications were similar to those of the whole group [10]. Our results in terms of EC loss evaluated 3 months after surgery are similar to those reported by all these authors [46]; however, the subjective limitation to exercise of our study population, resulted as being limited more because of respiratory symptoms than because of muscular leg fatigue.
Regarding PFT modification after lung resection, FEV1 resulted as being unchanged and a significant decrease in TLC was noted. Such findings, also reported by other authors [5,6,15,16], confirm the low value of FEV1 to predict postoperative EC and show a tendency of FEV1 to overestimate EC loss after lung resection. Furthermore, such PFT modifications could be interpreted as an improvement on bronchial airway obstruction related to relief of pulmonary hyperinflation and to a better respiratory muscle activity of the diaphragm secondary to lung resection [17]. However, since no preoperative nuclear medicine ventilation/perfusion scans were done, and no data on lung emphysema distribution at preoperative CT scan were collected, there is a lack of proof to support such a hypothesis.
Although various authors [18,19] recommend the use of the percentage of the predicted value of VO2max per kilogram of body weight in the evaluation of operative risk in functionally compromised patients, in the face of the low rate of postoperative complications encountered in the study we found that the use of a cutoff value of VO2max at more than 10 ml/Kg/min at peak of exercise can be considered an equally safe and appropriate method of selecting patients suitable for lobe resection [20].
In conclusion, the present study shows that COPD patients undergoing lobectomy may be found, 3 months after surgery, to have a persistent, significant EC loss in the absence of modifications of FEV1. Because of the small number of patients enrolled in the study and because of the wide range of COPD severity of the patients enrolled, no definitive conclusion can be drawn as to EC changes in COPD patients after lobectomy. Indeed, a much longer follow-up could better clarify the adjustment of cardio-pulmonary function in COPD patients after lung resection surgery.
| Footnotes |
|---|
Presented at the joint 18th Annual Meeting of the European Association for Cardio-thoracic Surgery and the 12th Annual Meeting of the European Society of Thoracic Surgeons, Leipzig, Germany, September 1215, 2004. | References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
K. Kushibe, T. Kawaguchi, M. Kimura, M. Takahama, T. Tojo, and S. Taniguchi Exercise capacity after lobectomy in patients with chronic obstructive pulmonary disease Interactive CardioVascular and Thoracic Surgery, June 1, 2008; 7(3): 398 - 401. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bobbio, A. Chetta, L. Ampollini, G. L. Primomo, E. Internullo, P. Carbognani, M. Rusca, and D. Olivieri Preoperative pulmonary rehabilitation in patients undergoing lung resection for non-small cell lung cancer Eur. J. Cardiothorac. Surg., January 1, 2008; 33(1): 95 - 98. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Nagamatsu, K. Maeshiro, N. Y. Kimura, T. Nishi, I. Shima, H. Yamana, and K. Shirouzu Long-term recovery of exercise capacity and pulmonary function after lobectomy. J. Thorac. Cardiovasc. Surg., November 1, 2007; 134(5): 1273 - 1278. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Varela, A. Brunelli, G. Rocco, M. F. Jimenez, M. Salati, and T. Gatani Evidence of Lower Alteration of Expiratory Volume in Patients With Airflow Limitation in the Immediate Period After Lobectomy Ann. Thorac. Surg., August 1, 2007; 84(2): 417 - 422. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Brunelli, F. Xiume, M. Refai, M. Salati, R. Marasco, V. Sciarra, and A. Sabbatini Evaluation of Expiratory Volume, Diffusion Capacity, and Exercise Tolerance Following Major Lung Resection: A Prospective Follow-up Analysis Chest, January 1, 2007; 131(1): 141 - 147. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Ferri, A. Cesario, F. Pasqua, and P. Granone Chronic obstructive pulmonary disease, surgery and pulmonary rehabilitation Eur. J. Cardiothorac. Surg., February 1, 2006; 29(2): 266 - 267. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |